1. Meaning 

Commercial Embryo Doctrine Accountability is a legal and ethical framework for determining who should be held responsible when human embryos created through in-vitro fertilisation (IVF) are sold, traded, misused, stored improperly, transferred without valid consent, or exploited for commercial gain.

The term is best understood as an analytical legal doctrine, rather than the name of a single universally recognised statute or binding judicial doctrine. Its principles are drawn from assisted reproductive technology (ART) legislation, medical negligence, informed consent, reproductive autonomy, contractual liability, privacy, human dignity and the regulation of commercial reproductive services.

The central question is:

When human embryos become part of a commercial reproductive system, who is accountable for protecting the interests of the genetic contributors, intended parents, future children and society?

The answer depends on the jurisdiction, the nature of the conduct, the consent given, and the applicable reproductive technology laws.

2. Essential elements of the doctrine

A. Prohibition of embryo trafficking

Commercial buying and selling of human embryos must be distinguished from lawful payment for IVF treatment, laboratory work, storage, and other legitimate clinical services. Where legislation expressly prohibits embryo sales, a private contract or commercial arrangement cannot legalise the prohibited transaction.

B. Informed and continuing consent

Clinics must respect the legally required consent of the people whose gametes were used and comply with the applicable conditions governing storage, use, donation and transfer. Consent to IVF treatment is not automatically consent to every later commercial or research use.

C. Institutional responsibility

Clinics, embryo banks, medical professionals, intermediaries and other regulated participants may be accountable for unauthorised transfers, falsified records, unlawful sales, unsafe storage or failures to follow statutory safeguards.

D. Remedies and enforcement

Depending on the applicable law, accountability can include criminal prosecution, regulatory sanctions, professional disciplinary action, civil damages, injunctions, compensation and orders governing the future handling of embryos.

3. Legal position in India

India has a specific statutory framework for assisted reproductive technology. The principal legislation is the Assisted Reproductive Technology (Regulation) Act, 2021, read with the applicable rules and related legislation.

Indian Kanoon

A. Section 33: offences and penalties

Section 33 is especially important to commercial embryo accountability. It prohibits specified conduct, including:

Selling human embryos or gametes.

Operating an agency, racket or organisation for trading in embryos or gametes.

Selling embryos or gametes for research.

Exploiting commissioning couples, women or gamete donors.

Abandoning, disowning or exploiting children born through ART.

Certain prohibited forms of importation and embryo transfer.

These prohibitions create a direct statutory basis for holding relevant individuals and organisations accountable for prohibited commercial activity. The precise offence and penalty must be determined from the statutory provision applicable to the facts.

Indian Kanoon

Important distinction: charging for legitimate medical procedures, laboratory services or embryo storage is not necessarily the same as selling an embryo. The legal question is what is being paid for and whether the transaction violates the statute.

B. Regulatory responsibility

Accountability can arise at several levels:

Liability is not automatic for every participant. The relevant offence, duty, knowledge, conduct and evidence must be established under the applicable law.

C. Section 29: restriction on sale and transfer

Section 29 addresses the restriction on the sale, transfer or use of human gametes, zygotes and embryos, including indirect transactions and transactions involving parties within or outside India. It contains a specific exception for transferring one's own gametes and embryos for personal use with permission from the National Board.

IndiaCode+1

This provision is central to commercial embryo accountability because it targets not only the physical sale of embryos but also specified indirect commercial arrangements.

D. Penalties under Section 33

Under Section 33(2) of the ART Act:

First contravention: a fine of ₹5 lakh to ₹10 lakh.

Subsequent contravention: imprisonment of three to eight years and a fine of ₹10 lakh to ₹20 lakh.

The applicable penalty depends on the particular prohibited conduct and whether the statutory conditions for a subsequent contravention are satisfied.

IndiaCode+1

Section 34 also provides a penalty for contraventions of the Act or rules for which no specific punishment is provided, as set out in that section. The ART Act should be read as a whole rather than treating every dispute involving an embryo as a criminal offence.

4. Important case laws

The following judgments establish principles relevant to embryo accountability. They are not all cases about commercial embryo sales; rather, they address consent, embryo status, reproductive autonomy and the legal limits on control over embryos.

Case 1: Davis v. Davis (1992)

Supreme Court of Tennessee, 842 S.W.2d 588 (1992)

Facts: A couple undergoing IVF created embryos that remained frozen after their relationship ended. They disagreed about whether the embryos should be used for reproduction or not used.

Legal issue: Whether frozen embryos should be treated as ordinary property and how competing reproductive interests should be balanced.

Decision: The court concluded that pre-embryos were neither persons in the strict legal sense nor ordinary property. They occupied an intermediate category deserving special respect. The genetic contributors had decision-making interests concerning their disposition. The court established a framework that considered the parties' preferences, their prior agreements and, where necessary, their competing reproductive interests.

Justia Law

Relevance to commercial embryo accountability:

An embryo should not automatically be treated as an ordinary commodity.

A clinic's contractual arrangements should respect the legally relevant interests of the genetic contributors.

Agreements concerning frozen embryos should clearly address storage, future use, donation and disposition.

Commercial interests should not displace legally protected reproductive interests.

Principle: Control over embryos requires a framework that respects reproductive autonomy and the special status of embryos, rather than assuming unrestricted ownership.

Case 2: Evans v. United Kingdom (2007)

European Court of Human Rights, Grand Chamber, Application No. 6339/05, judgment of 10 April 2007

Facts: Natallie Evans had undergone IVF with her former partner. After the relationship ended, he withdrew consent to the use of the stored embryos. Under the applicable British legislation, his continuing consent was required before implantation.

Legal issue: Whether the requirement for continuing consent violated the applicant's rights to private and family life and the other rights she invoked under the European Convention on Human Rights.

Decision: The Grand Chamber found no violation of Articles 2, 8 or 14 in the circumstances. It accepted that the competing reproductive interests were irreconcilable and that the law's requirement of continuing consent served legitimate objectives, including legal certainty and respect for individual autonomy.

HUDOC

Relevance to commercial embryo accountability:

A clinic cannot assume that consent given at the start of IVF authorises every subsequent use of an embryo.

Written consent arrangements must reflect the governing law.

Commercial agreements cannot simply override mandatory consent requirements.

Clinics should maintain reliable records of consent, withdrawal and permitted uses.

Principle: Reproductive autonomy and legally required consent can take priority over one party's desire to use an embryo, even where the consequences for that party are severe.

Case 3: R. v. Secretary of State for Health, ex parte Quintavalle (2003)

UK House of Lords, [2003] UKHL 13

Facts: The litigation concerned whether embryos created using cell-nuclear replacement techniques fell within the statutory definition of an embryo under British reproductive legislation.

Legal issue: How legislation regulating embryo creation and use should be interpreted in light of developing reproductive technology.

Decision: The House of Lords adopted an interpretation of the statutory framework that brought the relevant embryos within its regulatory scope. The judgment recognised the need to interpret legislation in a way that addresses the scientific techniques the regulatory scheme was intended to govern.

HUDOC

Relevance to commercial embryo accountability:

Emerging reproductive techniques should not automatically escape regulation merely because the technology is new.

Statutory definitions and licensing requirements are important safeguards against regulatory gaps.

Commercial providers must assess whether their activities fall within regulated categories rather than relying solely on labels used in contracts.

Principle: Regulatory accountability must be capable of responding to scientific developments within the proper interpretation of the legislation.

Case 4: Vo v. France (2004)

European Court of Human Rights, Grand Chamber, Application No. 53924/00

Facts: The case arose from medical negligence that resulted in the loss of a pregnancy.

Legal issue: Whether the unborn child was entitled to protection as a person under Article 2 of the European Convention on Human Rights.

Decision: The Court held that, in the absence of European consensus on the legal and scientific definition of the beginning of life, the question fell within the states' margin of appreciation. It did not establish a universal legal rule that every embryo has independent legal personality.

HUDOC

Relevance to commercial embryo accountability:

The judgment demonstrates why embryo regulation must distinguish between the legal protection afforded to embryos, the rights of people involved in reproduction and the separate question of whether an embryo has legal personality.

Principle: Embryo protection and legal personhood are distinct questions, and the applicable statute and jurisdiction matter.

Case 5: Indian Supreme Court — Surrogacy Regulation Act, 2021 transition dispute (judgment of 9 October 2025)

Supreme Court of India, judgment dated 9 October 2025

Facts and legal issue: The Supreme Court considered the effect of the Surrogacy (Regulation) Act, 2021 on intended parents whose embryos had been fertilised before the new statutory restrictions took effect.

Decision: The Court explained that certain rights had accrued to the intending couple before 25 January 2022 and were not automatically extinguished by the later legislation. The dispute concerned the transition between the earlier legal framework and the new surrogacy regime.

Sci API

Relevance to commercial embryo accountability:

Legislative changes may raise difficult questions about previously created embryos.

Clinics and intended parents need accurate records of the date of fertilisation and the consents and permissions applicable at that time.

Transitional rights do not create a general right to buy or sell embryos, nor do they displace other statutory prohibitions.

Principle: The legal treatment of existing embryos can depend on when they were created and the applicable transitional provisions.

These cases must be applied carefully: Davis is a US state-law decision, Evans and Vo concern European human-rights law, Quintavalle concerns UK statutory interpretation, and the Indian Supreme Court judgment concerns a particular transition in surrogacy regulation.

5. Applying the doctrine to practical disputes

These are illustrative applications, not automatic legal outcomes. In India, the ART Act's specific prohibitions must be considered alongside any other applicable legislation and the facts of the dispute.

6. The accountability framework

A comprehensive commercial embryo accountability regime should contain six safeguards.

Registration and licensing: Only appropriately registered and authorised institutions should conduct regulated ART activities.

Consent documentation: Clinics should maintain verifiable records covering creation, storage, transfer, donation, research and withdrawal of consent.

Financial transparency: Clinical fees, storage charges and other lawful payments should be distinguished from prohibited payments for embryos themselves.

Traceability: Records should establish the source, location and authorised use of stored embryos, subject to privacy safeguards.

Independent oversight: Regulators should investigate suspicious transactions, improper recordkeeping and non-compliance.

Effective remedies: The legal framework should provide appropriate sanctions, compensation where available, complaint mechanisms and judicial review.

7. Major legal challenges

A. Defining commercialisation: The law must distinguish prohibited embryo sales from lawful reproductive healthcare and laboratory services.

B. Determining legal status: Embryos are not classified identically across jurisdictions. Legal protection, ownership-like interests and legal personality are separate questions.

C. Cross-border transactions: Conflicting national laws can complicate embryo transfers, international fertility arrangements and enforcement.

D. Contractual uncertainty: Agreements may not anticipate relationship breakdown, death, incapacity, prolonged storage or changes in legislation.

E. Privacy and genetic information: Commercial exploitation may involve sensitive genetic and reproductive information, creating additional data-protection and confidentiality concerns.

F. Access and equality: Regulation must protect people against exploitation without unnecessarily obstructing lawful fertility treatment.

8. Conclusion

Commercial Embryo Doctrine Accountability can be understood as the principle that commercial activity involving human embryos must remain subordinate to statutory restrictions, informed consent, reproductive autonomy, medical responsibility and effective regulatory oversight.

In India, the strongest direct statutory foundations are Sections 29 and 33 of the Assisted Reproductive Technology (Regulation) Act, 2021. Section 29 restricts the sale, transfer and use of embryos and related materials, subject to its specified exception; Section 33 establishes offences and penalties for prohibited conduct.

IndiaCode+1

The leading comparative cases add important guidance: Davis v. Davis addresses embryo disposition, Evans v. United Kingdom emphasises continuing consent, and Quintavalle illustrates how reproductive legislation can be interpreted in light of scientific developments.

The central legal objective is not to prohibit every commercial service associated with IVF. It is to prevent prohibited embryo trading and exploitation while ensuring that legitimate treatment remains accountable, safe and consistent with the law.

For a deeper legal analysis, the next useful step would be to examine Commercial Embryo Accountability Governance Doctrine, focusing on the duties of regulators, ART clinics, embryo banks and intermediaries, with Indian statutory provisions and comparative case law.